CANCER TREATMENT USING CX26 BLOCKING PEPTIDES
- 专利权人:
- THE CLEVELAND CLINIC FOUNDATION
- 发明人:
- Justin D. Lathia,Ofer Reizes
- 申请号：
- US16326741
- 公开号：
- US20190352367A1
- 申请日:
- 2017.08.23
- 申请国别(地区):
- US
- 年份:
- 2019
- 代理人:
- 摘要：
- Blocking peptides that inhibit FAK or NANOG binding to Cx26, and a method of treating cancer by administering these blocking peptides to a subject in need thereof are described.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- USE OF PEPTIDES THAT BLOCK METADHERIN-SND1 INTERACTION AS TREATMENT FOR CANCER
- USE OF PEPTIDES THAT BLOCK METADHERIN- SND1 INTERACTION AS TREATMENT FOR CANCER
- Method for treating breast cancer by targeting breast cancer stem cell
- Treating cancer by blocking the interaction of TIM-3 and its ligand
- TREATING CANCER BY BLOCKING THE INTERACTION OF TIM-3 AND ITS LIGAND
